Value Equity Research
  • Home
  • Company Reports
  • Quarterly Snaphots
  • Capital Discipline Weekly
  • Capital Allocation League
  • About
Sign in Subscribe

Drug Manufacturers - General

Biogen Inc. (BIIB): Margin compression and cash conversion strain reshape return profile
Healthcare

Biogen Inc. (BIIB): Margin compression and cash conversion strain reshape return profile

Read More
Bristol-Myers Squibb Company (BMY): Margin recovery and earnings rebound amid revenue stagnation
Healthcare

Bristol-Myers Squibb Company (BMY): Margin recovery and earnings rebound amid revenue stagnation

Read More
Eli Lilly and Company (LLY): Margin expansion with rising scale and cost efficiency
Healthcare

Eli Lilly and Company (LLY): Margin expansion with rising scale and cost efficiency

Read More
Merck & Co., Inc. (MRK): Margin recovery and cash generation reshape return profile
Healthcare

Merck & Co., Inc. (MRK): Margin recovery and cash generation reshape return profile

Read More
AbbVie Inc. (ABBV): Heavy R&D investment reshapes cash generation and margins
Healthcare

AbbVie Inc. (ABBV): Heavy R&D investment reshapes cash generation and margins

Read More
Eli Lilly and Company (LLY): Margin expansion and cash generation reshape return profile
Healthcare

Eli Lilly and Company (LLY): Margin expansion and cash generation reshape return profile

Read More
Eli Lilly and Company (LLY): Margin expansion with rising operating efficiency and returns
Healthcare

Eli Lilly and Company (LLY): Margin expansion with rising operating efficiency and returns

Read More
Johnson & Johnson (JNJ): Cash generation and internal funding amid elevated reinvestment
Healthcare

Johnson & Johnson (JNJ): Cash generation and internal funding amid elevated reinvestment

Read More
Value Equity Research © 2026
  • Sign up
  • Disclaimer
Powered by Ghost